You are not authorized to access this page.

Oxford University Press

SHERPA: Unknown

People

  1. Tuttle
    Tuttle
  2. Breitbart
    Breitbart
  3. Brennan
    Brennan
  4. Saltz
    Saltz
  5. Fagin
    Fagin
  6. Ghossein
    Ghossein
  7. Motzer
    Motzer
  8. Sklar
    Sklar
  9. Massie
    Massie
  10. Postow
    Postow

Groups

  1. Department of Medicine (291)
  2. Solid Tumor Oncology Division (197)
  3. Survivorship Research (153)
  4. Surgery (151)
  5. Population Sciences Research Program (141)
  6. Division of Subspecialty Medicine (106)
  7. Psychiatry and Behavioral Sciences, Department of (94)
  8. Psychiatry Service (82)
  9. Center for Pancreatic Cancer Research (70)
  10. GSK Faculty (64)
Search Within
Formats
  1. Journal Article (489)
  2. Book Section (166)
  3. Review (25)
  4. Meeting Abstract (24)
  5. Editorial (12)
  6. Book Whole (11)
  7. Conference Paper (5)
  8. Correspondence (5)
  9. Research Letter (3)
  10. Guidelines (1)
  11. Miscellaneous (1)
Groups
  1. Department of Medicine (291)
  2. Solid Tumor Oncology Division (197)
  3. Survivorship Research (153)
  4. Surgery (151)
  5. Population Sciences Research Program (141)
  6. Division of Subspecialty Medicine (106)

More Groups

People
  1. Jimmie Holland (72)
  2. Julia Rowland (62)
  3. Robert Tuttle (34)
  4. William Breitbart (31)
  5. Mario Lacouture (17)
  6. Leonard Saltz (16)

More People

Years
  1. 2025 (22)
  2. 2024 (43)
  3. 2023 (39)
  4. 2022 (29)
  5. 2021 (37)
  6. 2020 (31)

More Years

Publications
  1. The Oncologist (291)
  2. Journal of Clinical Endocrinology and Metabolism (106)
  3. British Journal of Surgery (88)
  4. Handbook of Psychooncology: Psychological Care of the Patient with Cancer (62)
  5. Psycho-Oncology. 2nd ed (25)
  6. Diseases of the Esophagus (21)

More Publications

Results (742)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final database lock results of the phase 2 cohort of lenvatinib + pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Shah, A. Y.; Rao, A.; Taylor, M. H.; Pinto, A.; Sarrio, R. G.; Cohn, A. L.; Bilen, M. A.; Ribe, S. G.; Goksel, M.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Zanzalintinib in combination with immune checkpoint inhibitors: Design of the renal cell carcinoma expansion stage cohorts in STELLAR-002
    Meeting Abstract

    Motzer, R. J.; Choueiri, T. K.; Garmezy, B.; O'Neil, B.; Michalski, J.; Barata, P.; Bajaj, A.; Chahoud, J.; Liu, M.; Xu, F.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Molecular profiling of 50 734 Bethesda III-VI thyroid nodules by ThyroSeq v3: Implications for personalized management
    Journal Article

    Chiosea, S.; Hodak, S. P.; Yip, L.; Abraham, D.; Baldwin, C.; Baloch, Z.; Gulec, S. A.; Hannoush, Z. C.; Haugen, B. R.; Joseph, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2023)

    Fulltext@MSK | Save
  • Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: An E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE
    Guidelines

    Siriwardena, A. K.; Serrablo, A.; Fretland, Å. A.; Wigmore, S. J.; Ramia-Angel, J. M.; Malik, H. Z.; Stättner, S.; Søreide, K.; Zmora, O.; Meijerink, M.; more...
    British Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Patient characteristics associated with chemotherapy-induced peripheral neuropathy severity in a phase II clinical trial: A retrospective analysis
    Journal Article

    Zhi, W. I.; Dreyfus, N.; Lessing, A.; Galantino, M.; Piulson, L.; Kot, K. L.; Li, S.; Bao, T.
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Strategies to avoid mastectomy skin-flap necrosis during nipple-sparing mastectomy
    Journal Article

    Moo, T. A.; Nelson, J. A.; Sevilimedu, V.; Charyn, J.; Le, T. V.; Allen, R. J. Jr; Mehrara, B. J.; Barrio, A. V.; Capko, D. M.; Pilewskie, M.; more...
    British Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Atezolizumab plus PEGPH20 versus chemotherapy in advanced pancreatic ductal adenocarcinoma and gastric cancer: MORPHEUS phase Ib/II umbrella randomized study platform
    Journal Article

    Ko, A. H.; Kim, K. P.; Siveke, J. T.; Lopez, C. D.; Lacy, J.; O'Reilly, E. M.; Macarulla, T.; Manji, G. A.; Lee, J.; Ajani, J.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Aggressive subtypes of papillary microcarcinoma
    Editorial

    Shaha, A. R.
    Journal of Clinical Endocrinology and Metabolism (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions from the clear study in advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab
    Journal Article

    Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Puente, J.
    The Oncologist (2023)

    Fulltext@MSK | Save

    • Oxford University Press – authorized name for: